[Sofia, Bulgaria] — Comac Medical is delighted to announce the appointment of Christian Buhlmann as its new Chief Commercial Officer (CCO). Christian will officially be joining on the 1st of April, bringing with him over 25 years of experience in the healthcare and contract research organization (CRO) industries. Christian also offers innovative strategic vision, demonstrates strong capability to drive commercial growth and business development.
Christian Buhlmann: A Visionary Leader in Business Development
Christian is a distinguished executive recognized for his expertise in global sales, client relationship management, and market expansion. His ability to lead high-performing teams and foster strong partnerships has been instrumental in achieving consistent revenue growth and operational excellence. With vast experience across Europe, Asia, and North America, he has successfully built robust client networks and expanded businesses into new markets.
Christian’s deep expertise in business development and marketing strategy makes him a strong asset to Comac Medical’s leadership team. His strategic vision and proven track record in driving growth will be instrumental in advancing the company’s commercial success.
Along his career journey, Christian has consistently focused on fostering long-term partnerships and delivering impactful results in the healthcare and CRO industries. His leadership will further strengthen Comac Medical’s position in the global market.
Career Highlights
Christian has held key leadership positions in top-tier organizations, driving commercial success and operational excellence. As Executive VP of Business Development Global at a leading biotech company, he revitalized sales performance and redefined global business strategies. During his tenure as Head of Business Development at a prominent CRO, he built a high-performing sales team and led record-breaking growth across European and Asian markets.
Previously, as VP Strategic Business Development at a multinational CRO, Christian streamlined operations and enhanced efficiency across Europe and Asia-Pacific. Earlier in his career, as VP Business Development Europe at a global CRO, he successfully managed key accounts, securing major contracts and achieving significant sales milestones despite challenging market conditions.
“Christian’s results-driven approach and commitment to excellence align perfectly with our mission of advancing clinical research.” shares Vladimir Goranov, Co-CEO of Comac Medical. “His industry knowledge and ability to cultivate lasting partnerships will be instrumental in driving sustainable growth.” emphasises Rossitsa Vrabevska, Co-CEO of Comac Medical.
About Comac Medical
Comac Medical is a leading clinical research organization (CRO) and site management organization (SMO) with 27 years of experience in delivering high-quality solutions for clinical trials. Headquartered in Bulgaria, the company offers a full range of services across all phases of drug development, specializing in clinical operations, data management, regulatory affairs, and site management. Comac Medical partners with global pharmaceutical, biotechnology, and medical device companies to drive innovation, operational excellence, and improved patient outcomes, ensuring successful and efficient trial execution.
For more information, contact marketing@comac-medical.com.
